Capitalizing On Inflammation’s Role In Neurological Disease Part 1: Coya Therapeutics
koto_feja On this two-part article collection, I will evaluate two biotech investments, each concentrating on irritation ...
Read more
Tag: disease
Sagimet, NASH liver disease drug developer, sets terms for $75M IPO (Pending:SGMT)
Chunumunu Sagimet Biosciences (SGMT), which has been growing therapies for liver illnesses reminiscent of NASH, has ...
Read more
Novartis buys Chinook for $3.5 billion in race to treat rare kidney disease By Reuters
© Reuters. FILE PHOTO: The corporate's emblem is seen on the new cell and gene remedy ...
Read more